Andrew J. Steinle

Array ( [id] => 5694787 [patent_doc_number] => 20060154934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Combinations comprising antimuscarinic agents and PDE4 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/375308 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10403 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154934.pdf [firstpage_image] =>[orig_patent_app_number] => 11375308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747460 [patent_doc_number] => 20060110391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Compositions and methods for the treatment of body weight disorders, including obesity' [patent_app_type] => utility [patent_app_number] => 11/326489 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 40007 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110391.pdf [firstpage_image] =>[orig_patent_app_number] => 11326489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716176 [patent_doc_number] => 20060079539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Synergistic combination' [patent_app_type] => utility [patent_app_number] => 11/286391 [patent_app_country] => US [patent_app_date] => 2005-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2600 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079539.pdf [firstpage_image] =>[orig_patent_app_number] => 11286391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866104 [patent_doc_number] => 20060100235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Pharmaceutical use of substituted 1,2,4-triazoles' [patent_app_type] => utility [patent_app_number] => 11/246455 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32380 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100235.pdf [firstpage_image] =>[orig_patent_app_number] => 11246455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5881479 [patent_doc_number] => 20060030562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Use of an inhibitor of cathepsin-S-or-B to treat or prevent chronic obstructive pulmonary disease' [patent_app_type] => utility [patent_app_number] => 11/242411 [patent_app_country] => US [patent_app_date] => 2005-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11054 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030562.pdf [firstpage_image] =>[orig_patent_app_number] => 11242411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994098 [patent_doc_number] => 20070009443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Method for inhibiting occupation by rhinovirus of cell in the nasal membrane' [patent_app_type] => utility [patent_app_number] => 11/175913 [patent_app_country] => US [patent_app_date] => 2005-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2265 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009443.pdf [firstpage_image] =>[orig_patent_app_number] => 11175913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5766780 [patent_doc_number] => 20060018904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Combination therapies utilizing benzamide inhibitors of the P2X7 receptor' [patent_app_type] => utility [patent_app_number] => 11/168602 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23714 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018904.pdf [firstpage_image] =>[orig_patent_app_number] => 11168602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5771694 [patent_doc_number] => 20050267145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Treatment for lung cancer' [patent_app_type] => utility [patent_app_number] => 11/141655 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8006 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267145.pdf [firstpage_image] =>[orig_patent_app_number] => 11141655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5771684 [patent_doc_number] => 20050267135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Combinations comprising antimuscarinic agents and PDE4 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/141169 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10400 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267135.pdf [firstpage_image] =>[orig_patent_app_number] => 11141169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5771627 [patent_doc_number] => 20050267078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Combinations comprising antimuscarinic agents and beta-adrenergic agonists' [patent_app_type] => utility [patent_app_number] => 11/141428 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11221 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267078.pdf [firstpage_image] =>[orig_patent_app_number] => 11141428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978548 [patent_doc_number] => 20050288266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Combinations comprising antimuscarinic agents and corticosteroids' [patent_app_type] => utility [patent_app_number] => 11/141427 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10596 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288266.pdf [firstpage_image] =>[orig_patent_app_number] => 11141427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978588 [patent_doc_number] => 20050288306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase' [patent_app_type] => utility [patent_app_number] => 11/118064 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 50184 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288306.pdf [firstpage_image] =>[orig_patent_app_number] => 11118064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 509907 [patent_doc_number] => 07199126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase' [patent_app_type] => utility [patent_app_number] => 11/118065 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 58 [patent_no_of_words] => 50219 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/199/07199126.pdf [firstpage_image] =>[orig_patent_app_number] => 11118065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225540 [patent_doc_number] => 20050261354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase' [patent_app_type] => utility [patent_app_number] => 11/118066 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 50224 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261354.pdf [firstpage_image] =>[orig_patent_app_number] => 11118066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070093 [patent_doc_number] => 20050245478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Postoperative adjuvant chemotherapy with UFT' [patent_app_type] => utility [patent_app_number] => 11/115394 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5552 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245478.pdf [firstpage_image] =>[orig_patent_app_number] => 11115394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945350 [patent_doc_number] => 20050197399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Method of augmenting the antitumor activity of anticancer agents' [patent_app_type] => utility [patent_app_number] => 11/079633 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7123 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197399.pdf [firstpage_image] =>[orig_patent_app_number] => 11079633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020215 [patent_doc_number] => 20050222234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Mucin production inhibitor' [patent_app_type] => utility [patent_app_number] => 11/065567 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6303 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222234.pdf [firstpage_image] =>[orig_patent_app_number] => 11065567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6911789 [patent_doc_number] => 20050175547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases' [patent_app_type] => utility [patent_app_number] => 11/051463 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3389 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175547.pdf [firstpage_image] =>[orig_patent_app_number] => 11051463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6911791 [patent_doc_number] => 20050175549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Novel combination of anticholinergic and ss mimetics for the treatment of respiratory diseases' [patent_app_type] => utility [patent_app_number] => 11/051469 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2889 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175549.pdf [firstpage_image] =>[orig_patent_app_number] => 11051469 [rel_patent_id] =>[rel_patent_doc_number] =>)